Biglycan (BGN) (Middle Region) Peptid
BGN
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Biglycan (BGN) Produkte
- Biglycan (BGN)
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- DTTLLDLQNN DISELRKDDF KGLQHLYALV LVNNKISKIH EKAFSPLRKL
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- BGN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Biglycan (BGN) peptide
BGN Reaktivität: Human, Ratte, Hund, Maus Wirt: Synthetic BP, Imm
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Biglycan (BGN)
- Hintergrund
-
This gene encodes a member of the small leucine-rich proteoglycan (SLRP) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein, which plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity. Additionally, the encoded protein may contribute to atherosclerosis and aortic valve stenosis in human patients. This gene and the related gene decorin are thought to be the result of a gene duplication.
Alias Symbols: PGI, MRLS, DSPG1, PG-S1, SEMDX, SLRR1A
Protein Size: 368 - Gen-ID
- 633
- NCBI Accession
- NM_001711, NP_001702
- UniProt
- P21810
-
Sie sind hier:
